FDA Calendar for ZIOPHARM Oncology Inc. (ZIOP)

| Register (free)
ZIOPHARM Oncology, Inc. (ZIOPHARM) is a development-stage biopharmaceutical company. The Company focuses on developing and commercializing a portfolio of in-licensed cancer drugs that address unmet medical needs. The Company is focused on licensing and developing drug candidate families that are related to cancer therapeutics already on the market or in development and that can be developed in intravenous (IV) and/or oral forms of administration. As of December 31, 2008, it was in Phase I and Phase I/II studies for three product candidates known as darinaparsin (Zinapar ZIO-101), palifosfamide (Zymafos ZIO-201) and indibulin ( Zybulin ZIO-301).


Drug Pipeline

Drug NameType Of DrugFDA StatusDrug Phase
This company currently does not have any drugs. If you would like to create one please click here.


Events

No future events listed at this time, please check back later.
1 past event(s) found. Click here to view them.

Add New Event

In order to write a comment you must first login.

Login or Register (for free!)

Add Event

ZIOP

$5.69
0.10 +1.79%
2/3/2012 4:00:00 PM

Sponsors

Other Links